NOTCH3 Variants and Risk of Ischemic Stroke

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ross, Owen A ^a   Soto Ortolaza, Alexandra I ^a   Heckman, Michael G ^b   Verbeeck, Christophe ^a   Serie, Daniel J ^b   Rayaprolu, Sruti ^a   Rich, Stephen S ^c   Nalls, Michael A ^d   Singleton, Andrew ^d   Guerreiro, Rita ^d,e,f   Kinsella, Emma ^d,g   Wszolek, Zbigniew K ^b   Brott, Thomas G ^b   Brown Jr , Robert D ^h   Worrall, Bradford B ^c   Meschia, James F ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^h MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; NOTCH3 RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; CADASIL; CAUCASIAN; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; EXON; FEMALE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; RISK ASSESSMENT; RISK FACTOR; SIBLING;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NOTCH; RISK FACTORS; STROKE;

EID: 84884521546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075035     Document Type: Article

References (19)

1. Meschia JF, Worrall BB, Rich SS, (2011) Genetic susceptibility to ischemic stroke. Nat. Rev Neurol 7: 369-378. doi:10.1038/nrneurol.2011.80.
2. Ross OA, Worrall BB, Meschia JF, (2007) Advancing stroke therapeutics through genetic understanding. Curr Drug Targets 8: 850-859. doi:10.2174/138945007781077355. PubMed: 17630939.
3. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383: 707-710. doi:10.1038/383707a0. PubMed: 8878478.
4. Federico A, Bianchi S, Dotti MT, (2005) The spectrum of mutations for CADASIL diagnosis. Neurol Sci 26: 117-124. doi:10.1007/s10072-005-0444-3. PubMed: 15995828.
5. Dichgans M, (2003) Ch.6 Monogenic causes of ischaemic stroke. In: Markus H, eds. Stroke Genetics. Publ. Oxford Press. pp.pp. 165-195.
6. Guidetti D, Casali B, Mazzei RL, Dotti MT, (2006) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Exp Hypertens 28: 271-277. doi:10.1080/10641960600549223. PubMed: 16833034.
7. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN, (2002) CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12: 371-384. PubMed: 12146805.
8. Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, et al. (2008) A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci 267: 170-173. doi:10.1016/j.jns.2007.10.017. PubMed: 18022198.
9. Vikelis M, Papatriantafyllou J, Karageorgiou CE, (2007) A novel CADASIL-causing mutation in a stroke patient. Swiss Med Wkly 137: 323-325. PubMed: 17629811.
10. Fouillade C, Chabriat H, Riant F, Mine M, Arnoud M, et al. (2008) Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat 29: 452. doi:10.1002/humu.9526. PubMed: 18273901.
11. Arboleda-Velasquez JF, Zhou Z, Shin HK, Louvi A, Kim HH, et al. (2008) Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A 105: 4856-4861. doi:10.1073/pnas.0709867105. PubMed: 18347334.
12. (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41: 105-114. doi:10.1016/0895-4356(88)90084-4. PubMed: 3335877. doi:10.1016/0895-4356(88)90084-4 PubMed: 3335877.
13. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
14. Guerreiro RJ, Lohmann E, Kinsella E, Bras JM, Luu N, et al. (2011) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiol Aging.
15. Barrett JC, (2009) Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009: pdb ip71.
16. Dudoit S, van der Laan MJ, Pollard KS, (2004) Multiple testing. Part I. Single-step procedures for control of general type I error rates. Stat Appl Genet Mol Biol 3Article13.
17. Ramensky V, Bork P, Sunyaev S, (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30: 3894-3900. doi:10.1093/nar/gkf493. PubMed: 12202775.
18. Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, et al. (2011) Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain 134: 3384-3397. doi:10.1093/brain/awr252. PubMed: 22006983.
19. High FA, Epstein JA, (2008) The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet 9: 49-61. doi:10.1038/nrg2279. PubMed: 18071321.